Free Trial Information
BioCentury | Sep 24, 2020
Emerging Company Profile

Libra launches with $29M, three neurodegeneration programs to lower toxic protein levels

...chemical matter that modulates the pathway.Yonjin Venture, Dolby Family Ventures...
...Venture Fund, Epidarex Capital, Santé Ventures, Yonjin Venture, Dolby Family Ventures...
Read More
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...orally available cannabinoid receptor agonist in Phase I testing for neuroinflammation. The Cleveland Clinic Foundation, Dolby Family Ventures...
Read More
BioCentury | Jun 25, 2020
Deals

June 24 Quick Takes: CSL pays $450M for uniQure’s hemophilia gene therapy; plus Merck-Yumanity, Editas, Compass-Olivia, Century-Empirica, Tetraphase-La Jolla

...along with existing investors Fidelity, Redmile Group, Pfizer Ventures, Alexandria Venture Investments, Tony Coles and Dolby Family Ventures...
Read More
BioCentury | May 13, 2020
Emerging Company Profile

QurAlis taking three ALS programs toward clinic with $42M series A

...the Dementia Discovery Fund led the round. Also participating were Droia Ventures, Mitsui Global Investment, Dolby Family Ventures...
...Polaris Innovation Fund, Mission BioCapital, INKEF Capital, Dementia Discovery Fund, Droia Ventures, Mitsui Global Investment, Dolby Family Ventures...
Read More
BioCentury | Sep 14, 2018
Financial News

Neurological organoid company System1 raises $25M in series A

...million in a series A round co-led by CRV and Pfizer Ventures. Alexandria Venture Investments, Dolby Family Ventures...
Read More
BioCentury | Aug 17, 2018
Company News

BioMotiv, Cure Network developing inhibitory interneuron small molecules

...is a researcher at the Gladstone Institutes. The institute partnered with Evotec AG (Xetra:EVT) and Dolby Family Ventures...
...protein tau (tau; MAPT; FTDP-17). Cure Network spun out CNDAP in 2015 (see “Evotec, Gladstone, Dolby Family Ventures...
...provide details. BioMotiv LLC, Cleveland, Ohio Gladstone Institutes, San Francisco, Calif. Business: Neurology Jaime De Leon BioMotiv LLC Dolby Family Ventures...
Read More
BioCentury | Jun 1, 2018
Finance

Bacterial brain

...as well as existing investors Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures...
Read More
BioCentury | Jun 1, 2018
Financial News

Sequoia leads Cortexyme's $76M series B

...of Cortexyme’s previous investors -- Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures...
...series A round led by Pfizer. Cortexyme Inc., South San Francisco, Calif. Jaime De Leon COR388 Breakout Ventures Cortexyme Inc. Dolby Family Ventures Pfizer...
Read More
BioCentury | May 31, 2018
Financial News

Sequoia leads Cortexyme's $76M series B

...of Cortexyme’s previous investors -- Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures...
...Cortexyme raised $15 million in a series A round led by Pfizer. Jaime De Leon COR388 Breakout Ventures Cortexyme Inc. Dolby Family Ventures Pfizer...
Read More
BioCentury | Mar 9, 2018
Financial News

AI drug discovery company Atomwise raises $51M series A

...existing investors Y Combinator, Khosla Ventures and DFJ and new investors Baidu Ventures, Tencent and Dolby Family Ventures...
Read More
Items per page:
1 - 10 of 33
BioCentury | Sep 24, 2020
Emerging Company Profile

Libra launches with $29M, three neurodegeneration programs to lower toxic protein levels

...chemical matter that modulates the pathway.Yonjin Venture, Dolby Family Ventures...
...Venture Fund, Epidarex Capital, Santé Ventures, Yonjin Venture, Dolby Family Ventures...
Read More
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...orally available cannabinoid receptor agonist in Phase I testing for neuroinflammation. The Cleveland Clinic Foundation, Dolby Family Ventures...
Read More
BioCentury | Jun 25, 2020
Deals

June 24 Quick Takes: CSL pays $450M for uniQure’s hemophilia gene therapy; plus Merck-Yumanity, Editas, Compass-Olivia, Century-Empirica, Tetraphase-La Jolla

...along with existing investors Fidelity, Redmile Group, Pfizer Ventures, Alexandria Venture Investments, Tony Coles and Dolby Family Ventures...
Read More
BioCentury | May 13, 2020
Emerging Company Profile

QurAlis taking three ALS programs toward clinic with $42M series A

...the Dementia Discovery Fund led the round. Also participating were Droia Ventures, Mitsui Global Investment, Dolby Family Ventures...
...Polaris Innovation Fund, Mission BioCapital, INKEF Capital, Dementia Discovery Fund, Droia Ventures, Mitsui Global Investment, Dolby Family Ventures...
Read More
BioCentury | Sep 14, 2018
Financial News

Neurological organoid company System1 raises $25M in series A

...million in a series A round co-led by CRV and Pfizer Ventures. Alexandria Venture Investments, Dolby Family Ventures...
Read More
BioCentury | Aug 17, 2018
Company News

BioMotiv, Cure Network developing inhibitory interneuron small molecules

...is a researcher at the Gladstone Institutes. The institute partnered with Evotec AG (Xetra:EVT) and Dolby Family Ventures...
...protein tau (tau; MAPT; FTDP-17). Cure Network spun out CNDAP in 2015 (see “Evotec, Gladstone, Dolby Family Ventures...
...provide details. BioMotiv LLC, Cleveland, Ohio Gladstone Institutes, San Francisco, Calif. Business: Neurology Jaime De Leon BioMotiv LLC Dolby Family Ventures...
Read More
BioCentury | Jun 1, 2018
Finance

Bacterial brain

...as well as existing investors Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures...
Read More
BioCentury | Jun 1, 2018
Financial News

Sequoia leads Cortexyme's $76M series B

...of Cortexyme’s previous investors -- Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures...
...series A round led by Pfizer. Cortexyme Inc., South San Francisco, Calif. Jaime De Leon COR388 Breakout Ventures Cortexyme Inc. Dolby Family Ventures Pfizer...
Read More
BioCentury | May 31, 2018
Financial News

Sequoia leads Cortexyme's $76M series B

...of Cortexyme’s previous investors -- Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures...
...Cortexyme raised $15 million in a series A round led by Pfizer. Jaime De Leon COR388 Breakout Ventures Cortexyme Inc. Dolby Family Ventures Pfizer...
Read More
BioCentury | Mar 9, 2018
Financial News

AI drug discovery company Atomwise raises $51M series A

...existing investors Y Combinator, Khosla Ventures and DFJ and new investors Baidu Ventures, Tencent and Dolby Family Ventures...
Read More
Items per page:
1 - 10 of 33